Don P. Wilson
University of Arizona
58 Papers
209 Citations
Don P. Wilson is an academic researcher from University of Arizona. The author has contributed to research in topics: Medicine & Dyslipidemia. The author has an hindex of 14, co-authored 52 publications.
Chat about Author
Papers
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2.
Terry A. Jacobson,Kevin C. Maki,Carl E. Orringer,Peter B. Jones,Penny M. Kris-Etherton,Geeta Sikand,Ralph La Forge,Stephen R. Daniels,Don P. Wilson,Pamela B. Morris,Robert A. Wild,Scott M. Grundy,Martha L. Daviglus,Keith C. Ferdinand,Krishnaswami Vijayaraghavan,Prakash Deedwania,Judith A. Aberg,Katherine P. Liao,James M. McKenney,Joyce L. Ross,Lynne T. Braun,Matthew K. Ito,Harold E. Bays,W. Virgil Brown +23 more
TL;DR: This document represents a continuation of the National Lipid Association recommendations developed by a diverse panel of experts who examined the evidence base and provided recommendations regarding the following topics: lifestyle therapies and strategies to improve patient outcomes by increasing adherence and using team-based collaborative care.
802
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report
Terry A. Jacobson,Matthew K. Ito,Kevin C. Maki,Carl E. Orringer,Harold E. Bays,Peter B. Jones,James M. McKenney,Scott M. Grundy,Edward A. Gill,Robert A. Wild,Don P. Wilson,W. Virgil Brown +11 more
TL;DR: This document provides support for a consensus set of recommendations for patient-centered management of dyslipidemia in clinical medicine and an elevated level of cholesterol carried by circulating apolipoprotein B-containing lipoproteins is a root cause of atherosclerosis.
761
National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 – executive summary
Terry A. Jacobson,Matthew K. Ito,Kevin C. Maki,Carl E. Orringer,Harold E. Bays,Peter B. Jones,James M. McKenney,Scott M. Grundy,Edward A. Gill,Robert A. Wild,Don P. Wilson,W. Virgil Brown +11 more
TL;DR: The current Executive Summary highlights the major conclusions in Part 1 of the recommendations report of the NLA Expert Panel, which includes screening and classification of lipoprotein lipid levels in adults and targets for intervention in dyslipidemia management.
494
Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association.
Don P. Wilson,Terry A. Jacobson,Peter B. Jones,Marlys L. Koschinsky,Catherine J. McNeal,Børge G. Nordestgaard,Carl E. Orringer +6 more
TL;DR: In this scientific statement, an array of evidence-based considerations for testing of Lp(a) in clinical practice and the utilization of L p( a) levels to inform treatment strategies in primary and secondary prevention are reviewed.
442
Genetics of familial hypercholesterolemia.
Ariel Brautbar,Ariel Brautbar,Emili Leary,Emili Leary,Kristen Rasmussen,Don P. Wilson,Robert D. Steiner,Robert D. Steiner,Salim S. Virani +8 more
TL;DR: A brief overview of the genetic determinants, differential diagnosis, genetic testing, and counseling of FH genetics is provided.
86